Close
  Indian J Med Microbiol
 

Figure 1: On baseline positron emission tomography–computed tomography (a-d), the maximum intensity projection positron emission tomography image (a) shows focal areas of increased18F-fluorodeoxyglucose uptake in the lower half of the left leg (arrow) and the left inguinal region (broken arrow). No other abnormal18F-fluorodeoxyglucose uptake is seen in the rest of the body. Transaxial (b) and coronal (c) positron emission tomography–computed tomography images of the left leg demonstrate18F-fluorodeoxyglucose avid, ulceroproliferative circumferential cutaneous thickening (arrows) without any definite involvement of underlying muscles and bones. Transaxial positron emission tomography–computed tomography images (d) also show left inguinal18F-fluorodeoxyglucose-avid lymphadenopathy (broken arrow). The follow-up positron emission tomography–computed tomography done after 8 months (e-h) shows similar findings, but the reduction in18F-fluorodeoxyglucose avidity of both cutaneous lesion (f-g, arrows) and left inguinal node (h, broken arrow)

Figure 1: On baseline positron emission tomography–computed tomography (a-d), the maximum intensity projection positron emission tomography image (a) shows focal areas of increased<sup>18</sup>F-fluorodeoxyglucose uptake in the lower half of the left leg (arrow) and the left inguinal region (broken arrow). No other abnormal<sup>18</sup>F-fluorodeoxyglucose uptake is seen in the rest of the body. Transaxial (b) and coronal (c) positron emission tomography–computed tomography images of the left leg demonstrate<sup>18</sup>F-fluorodeoxyglucose avid, ulceroproliferative circumferential cutaneous thickening (arrows) without any definite involvement of underlying muscles and bones. Transaxial positron emission tomography–computed tomography images (d) also show left inguinal<sup>18</sup>F-fluorodeoxyglucose-avid lymphadenopathy (broken arrow). The follow-up positron emission tomography–computed tomography done after 8 months (e-h) shows similar findings, but the reduction in<sup>18</sup>F-fluorodeoxyglucose avidity of both cutaneous lesion (f-g, arrows) and left inguinal node (h, broken arrow)